Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology Annual Meeting 22h
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® for Follicular Lymphoma in Argentina and Mexico 17 March
